症状性子宫肌瘤行腹腔镜射频消融术后的生殖结局病例系列研究
该病例系列分析2010至2017年症状性子宫肌瘤患者接受经皮腹腔镜腹腔内超声引导射频消融(Lap-RFA)后的妊娠分娩与安全性结局,28例女性共妊娠30次,26次为足月活产(86.7%),均为健康婴儿,阴道分娩与剖宫产各半,自然流产4次(13.3%),未报告早产、子宫破裂、胎盘早剥、胎盘植入或宫内生长受限,各报告1例前置胎盘和产后出血。
要点
- 28例症状性子宫肌瘤患者Lap-RFA后共妊娠30次,26次足月活产(86.7%),婴儿均健康。
- 30次妊娠中自然流产4次(13.3%),未报告早产、子宫破裂、胎盘早剥、胎盘植入或宫内生长受限。
- 各报告1例前置胎盘和产后出血,阴道分娩与剖宫产各半。
核心结论
- 症状性子宫肌瘤行Lap-RFA后可以实现受孕和安全足月妊娠。
- 需要更多大型、严谨、多变量前瞻性研究,校正混杂因素并报告症状性子宫肌瘤治疗后的妊娠结局。
研究设计与样本
- 病例系列(2010-2017年),证据来自2项随机对照试验(level I)、6项队列研究(level II-2)及商业环境(level II-3)。
- 研究场所为美国、加拿大、欧洲和拉丁美洲的多家大学医院、社区医院和独立手术中心;商业病例基于美国,并在Lap-RFA获美国食品药品监督管理局许可后开展。
- 研究对象为有症状性子宫肌瘤(1至6型)的绝经前成年女性。
- 干预为全身麻醉下、腹腔镜和腹腔内超声引导的Lap-RFA。
- 共28例女性(平均年龄35.0 ± 3.4岁)在Lap-RFA后妊娠30次。
主要发现
- 每例患者治疗的肌瘤数量为1至7个,治疗肌瘤直径为0.9至11.0 cm。
- 多数患者有1或2个肌瘤,多数肌瘤最大直径≤5.5 cm。
- 30次妊娠中26次为足月活产(86.7%),婴儿均健康,阴道分娩与剖宫产各半。
- 自然流产4次(13.3%)。
- 未报告早产、子宫破裂、胎盘早剥、胎盘植入或宫内生长受限;各报告1例前置胎盘和产后出血。
局限性
- 需要更多大型、严谨、多变量前瞻性研究,校正混杂因素并报告症状性子宫肌瘤治疗后的妊娠结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To analyze pregnancy delivery and safety outcomes after patient receipt of percutaneous, laparoscopic intra-abdominal ultrasound-guided radiofrequency ablation (Lap-RFA) for symptomatic uterine myomas. DESIGN: Case series (2010-2017); evidence was obtained from 2 randomized, controlled trials (level I), 6 cohort studies (level II-2), and in commercial settings (level II-3). SETTING: Multiple sites in the United States, Canada, Europe, and Latin America (university hospitals, community hospitals, and stand-alone surgery centers). Commercial cases were United States based and followed US Food and Drug Administration clearance of Lap-RFA. PATIENTS: Premenopausal adult women with symptomatic uterine myoma types 1 through 6. INTERVENTIONS: The Lap-RFA procedure was conducted under general anesthesia with laparoscopic and intra-abdominal ultrasound guidance. MEASUREMENTS AND MAIN RESULTS: Safety unknowns included the safety of a full-term pregnancy for mother and baby, rates of spontaneous abortion, preterm delivery, postpartum hemorrhage, placental abnormalities, intrauterine growth restriction, and vaginal versus cesarean delivery. A total of 28 women (mean age = 35.0 ± 3.4 years) conceived a total of 30 times after Lap-RFA, either as part of a clinical study or in commercial settings. The number of myomas treated per patient ranged from 1 to 7. The diameter of treated myomas ranged from 0.9 to 11.0 cm. Most patients had 1 or 2 myomas, and most myomas were ≤5.5 cm in maximal diameter. The 30 pregnancies resulted in 26 full-term live births (86.7%), all healthy infants, with an equal distribution of vaginal and cesarean deliveries. Four (13.3%) spontaneous abortions occurred. No cases of preterm delivery, uterine rupture, placental abruption, placenta accreta, or intrauterine growth restriction were reported. One event each of placenta previa and postpartum hemorrhage were reported. CONCLUSION: Conception and safe, full-term pregnancy are achievable after Lap-RFA of symptomatic myomas. Additional large, rigorous, multivariate prospective studies that adjust for confounders and report pregnancy outcomes after symptomatic myoma treatment are needed.
引用
- Berman JM, Shashoua A, Olson C, et al. Case Series of Reproductive Outcomes after Laparoscopic Radiofrequency Ablation of Symptomatic Myomas. J Minim Invasive Gynecol. 2019. PMID: 31238151. doi:10.1016/j.jmig.2019.06.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。